GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Common Stock

Gemina Laboratories (XCNQ:GLAB) Common Stock : C$11.24 Mil (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Common Stock?

Gemina Laboratories's quarterly common stock stayed the same from Jul. 2023 (C$11.24 Mil) to Oct. 2023 (C$11.24 Mil) and stayed the same from Oct. 2023 (C$11.24 Mil) to Jan. 2024 (C$11.24 Mil).

Gemina Laboratories's annual common stock increased from Jan. 2022 (C$5.62 Mil) to Jan. 2023 (C$8.15 Mil) and increased from Jan. 2023 (C$8.15 Mil) to Jan. 2024 (C$11.24 Mil).


Gemina Laboratories Common Stock Historical Data

The historical data trend for Gemina Laboratories's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Common Stock Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Common Stock
0.99 5.62 8.15 11.24

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.15 11.24 11.24 11.24 11.24

Gemina Laboratories Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Gemina Laboratories (XCNQ:GLAB) Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines